Sinopharm, a dominant name in the distribution of pharmaceutical and healthcare products in China, continues to grab a...
Singapore: Marinomed Biotechnologie, a German company focused on the development of innovative therapies for respiratory...
Singapore: The Food and Drug Administration has recently issued a warning letter to China-based Novacyl Wuxi Pharmaceuti...
Sinopharm is jointly owned by China National Pharmaceutical Group and Shanghai Fosun Pharmaceutical. Directly contro...
Singapore: HIV drug developer, Gilead Sciences has partnered with Medicines Patent Pool (MPP) to expand access to Gilead...
Singapore: Days after China concluded its probe against British drug maker GlaxoSmithKline and charged certain executive...
Singapore: Ahead of the World AIDS Day, Mr Wang Guoqiang, vice director of the National Health and Family Planning Commi...
Singapore: US-based drugmaker Pfizer recently announced plans to stop selling Prevnar vaccine in China. The vaccine is a...
Singapore: China's research contract service provider, WuXi PharmaTech, has launched WuXi V-Lab, a mobile app available ...
Singapore: China-based Fosun diagnostics and Saladax Biomedical announced the launch of MyCare assay tests for chemother...
Singapore: Taiwan-based drugmaker, Liposome announced that it had received approval from the Chinese government to begin...
Singapore: A new research conducted by researchers at the Shanghai Jiao Tong University (SJTU), China, revealed that cer...
Singapore: According to reports, China's Guangxi Wuzhou Zhongheng Group recently announced plans to purchase a 10 percen...
Singapore: The Chinese government has now officially announced that the trial of the two private investigators tied to G...
Singapore: The 2nd annual BIO Convention in China, a partnering and investor conference that will bring together execut...
Singapore: China based Hangzhou Tigermed Consulting has acquired a majority of Frontage Laboratories, a company providin...
Singapore: After six new human cases of Avian Influenza H7N9 bird flu were reported from China last week, this week too ...
